Lista de obras -

A Case of Hereditary Hemorrhagic Telangiectasia Associated With Crohn's Disease Successfully Treated With Infliximab

artículo científico publicado en 2010

A case of pyoderma gangrenosum with ulcerative colitis treated with combined approach: infliximab and surgery

artículo científico publicado en 2012

Acute cytomegalovirus infection as a possible trigger for pulmonary thromboembolism in a patient with steroid-refractory ulcerative colitis.

artículo científico publicado en 2013

Adhesion molecules in inflammatory bowel disease: therapeutic implications for gut inflammation.

artículo científico publicado en 2005

Anti TNF-α therapy for ulcerative colitis: current status and prospects for the future.

artículo científico publicado en 2016

Anti-TNF-alpha therapies do not increase early postoperative complications in patients with inflammatory bowel disease. An Italian single-center experience

artículo científico publicado en 2011

Anti-TNF-α-induced psoriasiform lesions in IBD: an abnormal immune activation or a 'patchy cutaneous' immune suppression?

artículo científico publicado en 2013

Assessment of Crohn's Disease Activity: Magnetic Resonance Enterography in Comparison with Clinical and Endoscopic Evaluations

scientific article published on 01 June 2019

Benefit-risk assessment of golimumab in the treatment of refractory ulcerative colitis

artículo científico publicado en 2016

Biologic therapies in ulcerative colitis: primi inter pares?

artículo científico publicado en 2016

Biological therapies for inflammatory bowel disease: controversies and future options

artículo científico

Biological therapies for inflammatory bowel disease: research drives clinics.

artículo científico publicado en 2006

Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab.

artículo científico publicado en 2017

CD40L-positive platelets induce CD40L expression de novo in endothelial cells: adding a loop to microvascular inflammation

artículo científico publicado en 2004

Can We Predict the Efficacy of Anti-TNF-α Agents?

artículo científico publicado en 2017

Characterization of mucosal cytokine profile in ulcerative colitis patients under conventional and anti-TNF-a treatment

scientific article published on 23 September 2020

Clinical trial: oral colon-release parnaparin sodium tablets (CB-01-05 MMX) for active left-sided ulcerative colitis

artículo científico publicado en 2009

Combined therapy with infliximab and seton drainage for perianal fistulizing Crohn's disease with anal endosonographic monitoring: a single-centre experience

scientific article published on 10 June 2008

Comparison of Quantiferon-TB Gold versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease patients

scholarly article by Gianluca Andrisani et al published March 2013 in Journal of gastrointestinal and liver diseases : JGLD

Covid-19 and the management of patients with inflammatory bowel disease: a practical decalogue for the post-pandemic phase

artículo científico publicado en 2020

Dermatological adverse reactions during anti-TNF treatments: focus on inflammatory bowel disease.

artículo científico

Differentiation Affects the Release of Exosomes from Colon Cancer Cells and Their Ability to Modulate the Behavior of Recipient Cells

artículo científico publicado en 2017

Direct effect of infliximab on intestinal mucosa sustains mucosal healing: exploring new mechanisms of action

artículo científico publicado en 2015

Disappearance of gastric mucosa-associated lymphoid tissue in coeliac patients after gluten withdrawal.

artículo científico publicado en 1998

Editorial: The Role of Endoscopy in the Diagnosis and Follow-up of Low-Grade Gastric Mucosa-Associated Lymphoid Tissue Lymphoma ⬇️

artículo científico publicado el 1 de octubre de 1997

Effectiveness of Mesalazine, Thiopurines and Tumour Necrosis Factor Antagonists in Preventing Post-Operative Crohn's Disease Recurrence in a Real-Life Setting

artículo científico publicado en 2017

Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis

artículo científico publicado en 2016

Endoscopic findings and clinical patterns are not useful for distinguishing low from high grade gastric MALT lymphoma Reply ⬇️

artículo científico publicado el 1 de octubre de 1997

Eradication of Helicobacter pylori as the first step in the treatment of peptic stenosis

artículo científico publicado en 1996

Exacerbation of Crohn's disease as paradoxical effect of infliximab

artículo científico publicado en 2012

Extraintestinal manifestations in inflammatory bowel disease.

artículo científico publicado en 2005

FOXP3⁺ T regulatory cell modifications in inflammatory bowel disease patients treated with anti-TNFα agents

artículo científico publicado en 2013

Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year

article

Gastric Mucosa-Associated Lymphoid Tissue in Autoimmune Thyroid Diseases ⬇️

artículo científico publicado el 1 de septiembre de 1997

Gut Microbiota: A Key Modulator of Intestinal Healing in Inflammatory Bowel Disease.

artículo científico publicado en 2016

Harmful Effects and Potential Benefits of Anti-Tumor Necrosis Factor (TNF)-α on the Liver

artículo científico publicado en 2018

Helicobacter pylori CagA-positive strains affect oxygen free radicals generation by gastric mucosa.

artículo científico publicado en 2001

Helicobacter pylori eradication and remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma: a long-term follow-up study

artículo científico publicado en 2000

Helicobacter pylori eradication down-regulates matrix metalloproteinase-9 expression in chronic gastritis and gastric ulcer

artículo científico publicado en 2004

Helicobacter pylori eradication helps resolve pyloric and duodenal stenosis

artículo científico publicado en 1996

Helicobacter pylori eradication using one-week low-dose lansoprazole plus amoxycillin and either clarithromycin or azithromycin

scientific article published on 01 December 1996

Homocysteine triggers mucosal microvascular activation in inflammatory bowel disease.

artículo científico publicado en 2005

Human herpesvirus 8-associated colonic Kaposi's sarcoma during vedolizumab treatment in ulcerative colitis: a case report and review of the literature

scientific article published on 24 March 2020

IBD patients with COVID-19: the picture is taking shape

scientific article published on 18 August 2020

Immune response to influenza A/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-α agents: effects of combined therapy with immunosuppressants.

artículo científico publicado en 2012

Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre

artículo científico publicado en 2020

Infliximab does not increase colonic cancer risk associated to murine chronic colitis.

artículo científico publicado en 2016

Infliximab in steroid-dependent ulcerative colitis: effectiveness and predictors of clinical and endoscopic remission

artículo científico publicado en 2013

Inter-observer agreement in endoscopic scoring systems: preliminary report of an ongoing study from the Italian Group for Inflammatory Bowel Disease (IG-IBD).

artículo científico publicado en 2014

Intima-Media Thickness in Inflammatory Bowel Disease Patients: A Still Open Question

scientific article published on 01 February 2008

Is cytotoxic-associated gene A-positive Helicobacter pylori important?

scientific article published on 01 January 2001

Letter to the Editor: Winter is coming and COVID-19 vaccine is available! The role of gastroenterologist in increasing COVID-19 vaccine acceptability among IBD patients

artículo científico publicado en 2021

Locally injected Infliximab ameliorates murine DSS colitis: differences in serum and intestinal levels of drug between healthy and colitic mice.

artículo científico publicado en 2013

Long-term combination therapy with infliximab plus azathioprine predicts sustained steroid-free clinical benefit in steroid-dependent ulcerative colitis

artículo científico publicado en 2014

Low-dose omeprazole plus clarithromycin and either tinidazole or amoxycillin for Helicobacter pylori infection.

artículo científico publicado en 1996

Mucosal healing in ulcerative colitis: surveillance or colectomy?

artículo científico publicado en 2013

One‐week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus medium‐dose clarithromycin and either tinidazole or amoxycillin ⬇️

artículo científico publicado el 1 de junio de 1998

Onset of severe perianal disease in Crohn's disease under treatment with infliximab: successful treatment with adalimumab and setons drainage

scientific article published on 01 February 2011

Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up study.

artículo científico publicado en 2015

Predictive value of the Diverticular Inflammation and Complication Assessment (DICA) endoscopic classification on the outcome of diverticular disease of the colon: An international study

artículo científico publicado en 2015

Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agents.

artículo científico publicado en 2012

Prevalence of factor V Leiden and the G20210A prothrombin-gene mutation in inflammatory bowel disease.

artículo científico publicado en 2000

Prevalence of the K469E polymorphism of intercellular adhesion molecule 1 gene in Italian patients with inflammatory bowel disease.

artículo científico publicado en 2004

Prevention and treatment of low-grade B-cell primary gastric lymphoma by anti-H. pylori therapy

artículo científico publicado en 1995

Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: an open-label pilot study

artículo científico publicado en 2013

Primary hyperparathyroidism: acute paranoid psychosis

artículo científico publicado en 2003

Review article: the pathophysiology and medical management of diverticulosis and diverticular disease of the colon

artículo científico publicado en 2015

Role and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients: An update

artículo científico publicado en 2016

Role of Helicobacter pylori CagA+ infection in determining oxidative DNA damage in gastric mucosa.

artículo científico publicado en 2002

Role of dental plaque in the transmission of Helicobacter pylori infection

artículo científico publicado en 1996

Six-day or seven-day regimens with ranitidine bismuth citrate plus high-dose clarithromycin and tinidazole are both effective against Helicobacter pylori infection

scientific article published on 01 December 1999

The growth of primary low-grade B-cell gastric lymphoma is sustained by Helicobacter pylori

scientific article published on 01 March 1997

The impact of COVID-19 pandemic on IBD endoscopic procedures in a high-volume IBD Center

artículo científico publicado en 2020

Therapeutic drug monitoring of anti-TNF-α agents in inflammatory bowel diseases

artículo científico

Three-day antibiotic therapy with azithromycin and tinidazole plus lansoprazole or pantoprazole to cure Helicobacter pylori infection: a pilot study

artículo científico publicado en 1999

Training Programs on Endoscopic Scoring Systems for Inflammatory Bowel Disease Lead to a Significant Increase in Interobserver Agreement Among Community Gastroenterologists

artículo científico publicado en 2017

Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study.

artículo científico publicado en 2010

Use of infliximab in particular clinical settings: management based on current evidence

artículo científico publicado en 2009

Variation of the endoscopic pattern of low-grade gastric malt-lymphoma after Helicobacter pylori eradication ⬇️

artículo científico publicado el 1 de agosto de 1998

Vascular involvement in inflammatory bowel disease: pathogenesis and clinical aspects

artículo científico publicado en 2008

Venous Thromboembolism in Patients with Inflammatory Bowel Disease: The Role of Pharmacological Therapy and Surgery

artículo científico publicado en 2020

Venous thromboembolism in patients with inflammatory bowel disease: focus on prevention and treatment.

artículo científico publicado en 2014

What is the best azithromycin-based therapy for Helicobacter pylori infection?

artículo científico publicado en 1997

What is the best way to manage screening for infections and vaccination of inflammatory bowel disease patients?

artículo científico publicado en 2016

When can unfractionated heparin really be useful in the treatment of ulcerative colitis?

artículo científico publicado en 2001

Lista de obras de

A Case of Hereditary Hemorrhagic Telangiectasia Associated With Crohn's Disease Successfully Treated With Infliximab

A case of pyoderma gangrenosum with ulcerative colitis treated with combined approach: infliximab and surgery

Acute cytomegalovirus infection as a possible trigger for pulmonary thromboembolism in a patient with steroid-refractory ulcerative colitis.

Adhesion molecules in inflammatory bowel disease: therapeutic implications for gut inflammation.

Anti TNF-α therapy for ulcerative colitis: current status and prospects for the future.

Anti-TNF-alpha therapies do not increase early postoperative complications in patients with inflammatory bowel disease. An Italian single-center experience

Anti-TNF-α-induced psoriasiform lesions in IBD: an abnormal immune activation or a 'patchy cutaneous' immune suppression?

Assessment of Crohn's Disease Activity: Magnetic Resonance Enterography in Comparison with Clinical and Endoscopic Evaluations

Benefit-risk assessment of golimumab in the treatment of refractory ulcerative colitis

Biologic therapies in ulcerative colitis: primi inter pares?

Biological therapies for inflammatory bowel disease: controversies and future options

Biological therapies for inflammatory bowel disease: research drives clinics.

Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab.

CD40L-positive platelets induce CD40L expression de novo in endothelial cells: adding a loop to microvascular inflammation

Can We Predict the Efficacy of Anti-TNF-α Agents?

Characterization of mucosal cytokine profile in ulcerative colitis patients under conventional and anti-TNF-a treatment

Clinical trial: oral colon-release parnaparin sodium tablets (CB-01-05 MMX) for active left-sided ulcerative colitis

Combined therapy with infliximab and seton drainage for perianal fistulizing Crohn's disease with anal endosonographic monitoring: a single-centre experience

Comparison of Quantiferon-TB Gold versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease patients

Covid-19 and the management of patients with inflammatory bowel disease: a practical decalogue for the post-pandemic phase

Dermatological adverse reactions during anti-TNF treatments: focus on inflammatory bowel disease.

Differentiation Affects the Release of Exosomes from Colon Cancer Cells and Their Ability to Modulate the Behavior of Recipient Cells

Direct effect of infliximab on intestinal mucosa sustains mucosal healing: exploring new mechanisms of action

Disappearance of gastric mucosa-associated lymphoid tissue in coeliac patients after gluten withdrawal.

Editorial: The Role of Endoscopy in the Diagnosis and Follow-up of Low-Grade Gastric Mucosa-Associated Lymphoid Tissue Lymphoma ⬇️

Effectiveness of Mesalazine, Thiopurines and Tumour Necrosis Factor Antagonists in Preventing Post-Operative Crohn's Disease Recurrence in a Real-Life Setting

Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis

Endoscopic findings and clinical patterns are not useful for distinguishing low from high grade gastric MALT lymphoma Reply ⬇️

Eradication of Helicobacter pylori as the first step in the treatment of peptic stenosis

Exacerbation of Crohn's disease as paradoxical effect of infliximab

Extraintestinal manifestations in inflammatory bowel disease.

FOXP3⁺ T regulatory cell modifications in inflammatory bowel disease patients treated with anti-TNFα agents

Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year

Gastric Mucosa-Associated Lymphoid Tissue in Autoimmune Thyroid Diseases ⬇️

Gut Microbiota: A Key Modulator of Intestinal Healing in Inflammatory Bowel Disease.

Harmful Effects and Potential Benefits of Anti-Tumor Necrosis Factor (TNF)-α on the Liver

Helicobacter pylori CagA-positive strains affect oxygen free radicals generation by gastric mucosa.

Helicobacter pylori eradication and remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma: a long-term follow-up study

Helicobacter pylori eradication down-regulates matrix metalloproteinase-9 expression in chronic gastritis and gastric ulcer

Helicobacter pylori eradication helps resolve pyloric and duodenal stenosis

Helicobacter pylori eradication using one-week low-dose lansoprazole plus amoxycillin and either clarithromycin or azithromycin

Homocysteine triggers mucosal microvascular activation in inflammatory bowel disease.

Human herpesvirus 8-associated colonic Kaposi's sarcoma during vedolizumab treatment in ulcerative colitis: a case report and review of the literature

IBD patients with COVID-19: the picture is taking shape

Immune response to influenza A/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-α agents: effects of combined therapy with immunosuppressants.

Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre

Infliximab does not increase colonic cancer risk associated to murine chronic colitis.

Infliximab in steroid-dependent ulcerative colitis: effectiveness and predictors of clinical and endoscopic remission

Inter-observer agreement in endoscopic scoring systems: preliminary report of an ongoing study from the Italian Group for Inflammatory Bowel Disease (IG-IBD).

Intima-Media Thickness in Inflammatory Bowel Disease Patients: A Still Open Question

Is cytotoxic-associated gene A-positive Helicobacter pylori important?

Letter to the Editor: Winter is coming and COVID-19 vaccine is available! The role of gastroenterologist in increasing COVID-19 vaccine acceptability among IBD patients

Locally injected Infliximab ameliorates murine DSS colitis: differences in serum and intestinal levels of drug between healthy and colitic mice.

Long-term combination therapy with infliximab plus azathioprine predicts sustained steroid-free clinical benefit in steroid-dependent ulcerative colitis

Low-dose omeprazole plus clarithromycin and either tinidazole or amoxycillin for Helicobacter pylori infection.

Mucosal healing in ulcerative colitis: surveillance or colectomy?

One‐week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus medium‐dose clarithromycin and either tinidazole or amoxycillin ⬇️

Onset of severe perianal disease in Crohn's disease under treatment with infliximab: successful treatment with adalimumab and setons drainage

Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up study.

Predictive value of the Diverticular Inflammation and Complication Assessment (DICA) endoscopic classification on the outcome of diverticular disease of the colon: An international study

Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agents.

Prevalence of factor V Leiden and the G20210A prothrombin-gene mutation in inflammatory bowel disease.

Prevalence of the K469E polymorphism of intercellular adhesion molecule 1 gene in Italian patients with inflammatory bowel disease.

Prevention and treatment of low-grade B-cell primary gastric lymphoma by anti-H. pylori therapy

Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: an open-label pilot study

Primary hyperparathyroidism: acute paranoid psychosis

Review article: the pathophysiology and medical management of diverticulosis and diverticular disease of the colon

Role and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients: An update

Role of Helicobacter pylori CagA+ infection in determining oxidative DNA damage in gastric mucosa.

Role of dental plaque in the transmission of Helicobacter pylori infection

Six-day or seven-day regimens with ranitidine bismuth citrate plus high-dose clarithromycin and tinidazole are both effective against Helicobacter pylori infection

The growth of primary low-grade B-cell gastric lymphoma is sustained by Helicobacter pylori

The impact of COVID-19 pandemic on IBD endoscopic procedures in a high-volume IBD Center

Therapeutic drug monitoring of anti-TNF-α agents in inflammatory bowel diseases

Three-day antibiotic therapy with azithromycin and tinidazole plus lansoprazole or pantoprazole to cure Helicobacter pylori infection: a pilot study

Training Programs on Endoscopic Scoring Systems for Inflammatory Bowel Disease Lead to a Significant Increase in Interobserver Agreement Among Community Gastroenterologists

Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study.

Use of infliximab in particular clinical settings: management based on current evidence

Variation of the endoscopic pattern of low-grade gastric malt-lymphoma after Helicobacter pylori eradication ⬇️